LeonardTHeffnerMD
Hematology • Atlanta, GAProfessor, Hematology and Medical Oncology, Emory University School of Medicine
Dr. Heffner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1365 Clifton Rd Ne
Atlanta, GA 30322Phone+1 404-778-1900- Is this information wrong?
Education & Training
Emory University School of MedicineResidency, Internal Medicine, 1973 - 1974
University of Miami/Jackson Health SystemResidency, Internal Medicine, 1972 - 1973
Baylor College of MedicineResidency, Internal Medicine, 1971 - 1972- Emory University School of MedicineResidency, Internal Medicine, 1970 - 1970
- Emory University School of MedicineInternship, Internal Medicine, 1969 - 1970
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1969
Certifications & Licensure
GA State Medical License 1973 - 2023
NC State Medical License 1969 - 2022
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Clinical Trials
- Liposomal Vincristine Plus Dexamethasone in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Start of enrollment: 2002 Jul 01
- Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens Start of enrollment: 2006 Jul 01
- Safety and Dose Ranging Study of Samalizumab to Treat Relapsing or Refractory CLL or MM Start of enrollment: 2008 Jun 19
- Join now to see all
Publications & Presentations
PubMed
- Plain Language Summary of the iNNOVATE study: ibrutinib plus rituximab is well-tolerated and effective in people with Waldenström's macroglobulinemia.Christian Buske, Alessandra Tedeschi, Judith Trotman, Ramón García-Sanz, David MacDonald, Veronique Leblond, Beatrice Mahe, Charles Herbaux, Jeffrey V Matous, Constant...> ;Future Oncology. 2023 Feb 1
- 1 citationsVenetoclax ex vivo functional profiling predicts improved progression-free survival.Vikas A Gupta, Shannon M Matulis, Benjamin G Barwick, R Devin Bog, Conrad W Shebelut, Mala Shanmugam, Paola Neri, Nizar J Bahlis, Madhav V Dhodapkar, Leonard T Heffner...> ;Blood Cancer Journal. 2022 Aug 4
- 2 citationsBenefits of Autologous Stem Cell Transplantation for Elderly Myeloma Patients in the Last Quarter of Life.Nisha Joseph, Vikas Gupta, Sarah Wyman, Michael Graiser, Jonathan L. Kaufman, Dhwani Almaula, Joel Andrews, Craig C. Hofmeister, Madhav V. Dhodapkar, Leonard T. Heffne...> ;Transplantation and Cellular Therapy. 2021 Oct 6
- Join now to see all
Abstracts/Posters
- Phase II Trial of Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized with NFKB2 Rearrangement. (Proteasome Inhibitor NFKB2 Rearrang...Leonard Heffner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Phase II Trial of Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized with NFKB2 Rearrangement. (Proteasome Inhibitor NFKB2 Rearrang...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Outcomes of Myeloma Patients with Deletion 1p Receiving Lenalidomide, Bortezomib, and Dexamethasone (RVD) Therapy2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Professional Memberships
- Member
- Member
Hospital Affiliations
Emory University HospitalAtlanta, Georgia
Emory University Hospital MidtownAtlanta, Georgia
Grady Memorial HospitalAtlanta, Georgia
Southern Regional Medical CenterRiverdale, Georgia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
